These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31333791)

  • 61. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C.
    Tao J; Liu Z; Wang Y; Wang L; Yao B; Li Q; Wang C; Tu K; Liu Q
    Biomed Pharmacother; 2017 Sep; 93():420-428. PubMed ID: 28666208
    [TBL] [Abstract][Full Text] [Related]  

  • 62. miR-23c suppresses tumor growth of human hepatocellular carcinoma by attenuating ERBB2IP.
    Zhang L; Wang Y; Wang L; Yin G; Li W; Xian Y; Yang W; Liu Q
    Biomed Pharmacother; 2018 Nov; 107():424-432. PubMed ID: 30103114
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.
    Jin F; Wang Y; Li M; Zhu Y; Liang H; Wang C; Wang F; Zhang CY; Zen K; Li L
    Cell Death Dis; 2017 Jan; 8(1):e2540. PubMed ID: 28079894
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
    Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Loss of miR-638 promotes invasion and epithelial-mesenchymal transition by targeting SOX2 in hepatocellular carcinoma.
    Zhang Y; Zhang D; Jiang J; Dong L
    Oncol Rep; 2017 Jan; 37(1):323-332. PubMed ID: 27878280
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients' prognosis and tumor cell proliferation.
    Chen HW; Huang XD; Li HC; He S; Ni RZ; Chen CH; Peng C; Wu G; Wang GH; Wang YY; Zhao YH; Zhang YX; Shen AG; Wang HM
    Mol Carcinog; 2013 Aug; 52(8):647-59. PubMed ID: 22488567
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
    BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
    [TBL] [Abstract][Full Text] [Related]  

  • 69. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
    Huang X; Gao Y; Qin J; Lu S
    Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G559-G565. PubMed ID: 29097358
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inflammation and ER stress downregulate BDH2 expression and dysregulate intracellular iron in macrophages.
    Zughaier SM; Stauffer BB; McCarty NA
    J Immunol Res; 2014; 2014():140728. PubMed ID: 25762501
    [TBL] [Abstract][Full Text] [Related]  

  • 71. BDH2 triggers ROS-induced cell death and autophagy by promoting Nrf2 ubiquitination in gastric cancer.
    Liu JZ; Hu YL; Feng Y; Jiang Y; Guo YB; Liu YF; Chen X; Yang JL; Chen YY; Mao QS; Xue WJ
    J Exp Clin Cancer Res; 2020 Jun; 39(1):123. PubMed ID: 32605589
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma.
    Yao Z; Jia C; Tai Y; Liang H; Zhong Z; Xiong Z; Deng M; Zhang Q
    Aging (Albany NY); 2020 Jun; 12(12):11843-11863. PubMed ID: 32554864
    [TBL] [Abstract][Full Text] [Related]  

  • 73. KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma.
    Li WC; Xiong ZY; Huang PZ; Liao YJ; Li QX; Yao ZC; Liao YD; Xu SL; Zhou H; Wang QL; Huang H; Zhang P; Lin JZ; Liu B; Ren J; Hu KP
    Aging (Albany NY); 2019 Oct; 11(19):8169-8182. PubMed ID: 31581133
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Decreased expression of ApoF associates with poor prognosis in human hepatocellular carcinoma.
    Wang YB; Zhou BX; Ling YB; Xiong ZY; Li RX; Zhong YS; Xu MX; Lu Y; Liang H; Chen GH; Yao ZC; Deng MH
    Gastroenterol Rep (Oxf); 2019 Oct; 7(5):354-360. PubMed ID: 31687155
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inactivation of 3-hydroxybutyrate dehydrogenase type 2 promotes proliferation and metastasis of nasopharyngeal carcinoma by iron retention.
    Li B; Liao Z; Mo Y; Zhao W; Zhou X; Xiao X; Cui W; Feng G; Zhong S; Liang Y; Du C; Huang G; Li P; Xiao X; Zhou X; Wang R; Zhang Z
    Br J Cancer; 2020 Jan; 122(1):102-110. PubMed ID: 31819181
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The ketone body β-Hydroxybutyrate as a fuel source of chondrosarcoma cells.
    Vargas-López M; Quiroz-Vicente CA; Pérez-Hernández N; Gómez-Chávez F; Bañuelos-Hernández AE; Pérez-Hernández E
    Heliyon; 2024 May; 10(9):e30212. PubMed ID: 38694129
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches.
    Hashemi M; Nadafzadeh N; Imani MH; Rajabi R; Ziaolhagh S; Bayanzadeh SD; Norouzi R; Rafiei R; Koohpar ZK; Raei B; Zandieh MA; Salimimoghadam S; Entezari M; Taheriazam A; Alexiou A; Papadakis M; Tan SC
    Cell Commun Signal; 2023 Feb; 21(1):32. PubMed ID: 36759819
    [TBL] [Abstract][Full Text] [Related]  

  • 78. PTEN-knockout regulates metabolic rewiring and epigenetic reprogramming in prostate cancer and chemoprevention by triterpenoid ursolic acid.
    Wang L; Wang C; Sarwar MS; Chou P; Wang Y; Su X; Kong AT
    FASEB J; 2022 Nov; 36(11):e22626. PubMed ID: 36305462
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Potential Role of Exosomal Proteins in Prostate Cancer.
    Feng S; Lou K; Zou X; Zou J; Zhang G
    Front Oncol; 2022; 12():873296. PubMed ID: 35747825
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Long Non-coding RNAs With
    Weidle UH; Birzele F
    Cancer Genomics Proteomics; 2022; 19(4):372-389. PubMed ID: 35732324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.